Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival T. Jared Bunch, MD, Stephen C. Hammill, MD, Roger.

Slides:

Advertisements

Similar presentations

The MADIT II Trial Multicenter Autonomic Defibrillator Implantation Trial II Presented at the American College of Cardiology 51st Annual Scientific Session.

Advertisements

Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.

EP show – June 2004 EP show The EP show: Risk stratification for sudden death Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent.

EP Show – Dec 2003 ICDs – Primary prevention The EP Show: Guidelines and reimbursement at the crossroads: Primary prevention with ICDs Eric Prystowsky.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACC/AHA/ESC 2006 Guidelines for Management of Patients.

Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Reduction in Ventricular Tachyarrhythmias With Statins.

Date of download: 6/26/2016 Copyright © The American College of Cardiology. All rights reserved. From: Clinical Effectiveness of CRT and ICD Therapy in.

My Treatment Approach to Hairy Cell Leukemia Rahul R. Naik, MD, Alan Saven, MD Mayo Clinic Proceedings Volume 87, Issue 1, Pages (January 2012) DOI:

Date of download: 7/9/2016 From: Cost-Effectiveness of Implantable Cardioverter Defibrillators Relative to Amiodarone for Prevention of Sudden Cardiac.

Celebrating the Sesquicentennial of Mayo Clinic: 150 Years of Advances in Medical Practice, Education, Research, and Professionalism William L. Lanier,

Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in CKD: A Meta-analysis of Patient-Level Data From 3 Randomized.

Marc H. Bivins, MD, Mark J. Callahan, MD Mayo Clinic Proceedings

Wearable cardioverter-defibrillator for prevention of sudden cardiac death after infected implantable cardioverter-defibrillator removal: A cost-effectiveness.

Charles D. Burger, MD, Roger K. Resar, MD Mayo Clinic Proceedings

Alois A. Obwegeser, MD, Ryan J. Uitti, MD, Margaret F

Atrial Fibrillation in the 21st Century: A Current Understanding of Risk Factors and Primary Prevention Strategies Arthur R. Menezes, MD, Carl J. Lavie,

Evaluation of Proteinuria

Canadian Cardiovascular Society Guidelines on the Use of Cardiac Resynchronization Therapy: Evidence and Patient Selection Derek V. Exner, MD, MPH, David.

William L. Lanier, MD Mayo Clinic Proceedings

Diagnosis and Management of Chronic Kidney Disease

The Impact of Migraine and the Effect of Migraine Treatment on Workplace Productivity in the United States and Suggestions for Future Research Wayne.

Charles D. Burger, MD, Roger K. Resar, MD Mayo Clinic Proceedings

A Comparison of Long- and Short-Acting Opioids for the Treatment of Chronic Noncancer Pain: Tailoring Therapy to Meet Patient Needs Charles E. Argoff,

Treatment of Alcohol Withdrawal in Hospitalized Patients

Volume 68, Issue 2, Pages (August 2005)

Acquired Long QT Syndrome and Monomorphic Ventricular Tachycardia After Alternative Treatment With Cesium Chloride for Brain Cancer Anuj K. Dalal, MD,

Volume 5, Issue 6, Pages (June 2008)

Utility of Left Ventricular Ejection Fraction Measurements Before the Administration of Doxorubicin-Based Chemotherapy in Patients With Diffuse Large.

Julia A. Files, MD, Marcia G. Ko, MD, Sandhya Pruthi, MD

Palliative Care and Hospice Programs

Volume 11, Issue 1, Pages (January 2014)

The “Spiked Helmet” Sign: A New Electrocardiographic Marker of Critical Illness and High Risk of Death Laszlo Littmann, MD, PhD, Michael H. Monroe, MD

69-Year-Old Woman With Rapid Heartbeat

Acupuncture Mayo Clinic Proceedings

Misconceptions and Facts About Hypertrophic Cardiomyopathy

The Vascular-Renal Connection in Patients Hospitalized With Hypertensive Crisis: A Population-Based Study Siu-Hin Wan, MD, Joshua P. Slusser, BS, David.

David F. Katz et al. JACEP 2016;j.jacep

Volume 11, Issue 2, Pages (February 2014)

Neurologic Recovery Following Prolonged Out-of-Hospital Cardiac Arrest With Resuscitation Guided by Continuous Capnography Roger D. White, MD, Bruce.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

3 to 4 million patients fit the entry criteria

Marc H. Bivins, MD, Mark J. Callahan, MD Mayo Clinic Proceedings

2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation: Physiologic and Educational Rationale for Changes Roger D. White, MD Mayo.

Magali P. Disdier Moulder, PharmD, PhD, Jenna M

Mary Jane Rasmussen, RN, Paul A. Friedman, MD, Stephen C

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

Treating Tobacco Dependence in Light of the 2008 US Department of Health and Human Services Clinical Practice Guideline J. Taylor Hays, MD, Jon O. Ebbert,

Joanna Zurko, MD, Amitkumar Mehta, MD

David F. Katz et al. JACEP 2017;3:20-28

Volume 12, Issue 10, Pages (October 2015)

Volume 15, Issue 1, Pages (January 2018)

The Valsalva Maneuver—3 Centuries Later

Appropriate use of genetics in a young patient with atrioventricular block and family history of sudden cardiac death Johnni Rudbeck-Resdal, MD, Jens.

Osteoporosis Associated With Megestrol Acetate

Evaluating the Patient With Diarrhea: A Case-Based Approach

Institutional Review Boards: What Clinician Researchers Need to Know

Simon M. Glynn, MD, Sean J. Pittock, MD, Steven A. Vernino, MD, PhD

Hepatocellular Carcinoma

Pulmonary Tumor Embolism of Unknown Origin

Celebrating the Sesquicentennial of Mayo Clinic: 150 Years of Advances in Medical Practice, Education, Research, and Professionalism William L. Lanier,

Jamie Newman, MD, MHA, Renee E. Ziemer, BA

Medical Treatment of Overactive Bladder: In Response

Suboptimal Response to or Failure of Imatinib Treatment for Chronic Myeloid Leukemia: What Is the Optimal Strategy? Elias Jabbour, MD, Jorge E. Cortes,

Preoperative Smoking Cessation: The Role of the Primary Care Provider

Current Concepts in Laboratory Testing to Guide Antimicrobial Therapy

Guy S. Reeder, M.D. Mayo Clinic Proceedings

Pneumococcal Bacteremia: Lessons Learned, Yet More to Learn

Autonomic Tone and Benefits of Cardiac Rehabilitation Programs

Guru Sonpavde, MD, Teresa G. Hayes, MD Mayo Clinic Proceedings

Survival free of atrial fibrillation after implantation of an implantable cardioverter defibrillator in our series (151 patients): overall population (solid.

Presentation transcript:

Outcomes After Ventricular Fibrillation Out-of-Hospital Cardiac Arrest: Expanding the Chain of Survival T. Jared Bunch, MD, Stephen C. Hammill, MD, Roger D. White, MD Mayo Clinic Proceedings Volume 80, Issue 6, Pages 774-782 (June 2005) DOI: 10.4065/80.6.774 Copyright © 2005 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 1 A comparison of published ventricular fibrillation out-of-hospital cardiac arrest survival percentages in various US cities before (white bars) and after (black bars) an emergency medical services-based early defibrillation program was instituted. Mayo Clinic Proceedings 2005 80, 774-782DOI: (10.4065/80.6.774) Copyright © 2005 Mayo Foundation for Medical Education and Research Terms and Conditions

FIGURE 2 Early management strategy for ventricular fibrillation (VF) out-of-hospital cardiac arrest (OHCA) survivors after hospital admission to decrease early and long-term risk of recurrent sudden death. Asterisk indicates patients with persistent left ventricular dysfunction and nonsustained ventricular tachycardia (VT) reenter for consideration of implantable cardioverter-defibrillator (ICD) therapy via Multicenter Unsustained Tachycardia Trial (MUSTT) and Multicenter Automatic Defibrillator Implantation Trial I (MADIT I) criteria. Mayo Clinic Proceedings 2005 80, 774-782DOI: (10.4065/80.6.774) Copyright © 2005 Mayo Foundation for Medical Education and Research Terms and Conditions